We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
-13.45%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$123M
AUM Growth
-$23.8M
Cap. Flow
-$3.06M
Cap. Flow %
-2.49%
Top 10 Hldgs %
38.62%
Holding
73
New
3
Increased
15
Reduced
31
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 24.48%
2 Technology 16.77%
3 Financials 16.46%
4 Industrials 11.95%
5 Communication Services 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
1
Intel
INTC
$466B
$5.65M 4.6%
120,324
-743
-0.6% -$34.8K
AAPL icon
2
Apple
AAPL
$4.89T
$5.49M 4.47%
139,112
-1,888
-1% -$91.5K
HSY icon
3
Hershey
HSY
$35.4B
$5.09M 4.15%
47,536
-280
-0.6% -$29.8K
MDLZ icon
4
Mondelez International
MDLZ
$77.7B
$4.98M 4.06%
124,466
-786
-0.6% -$33.5K
BIIB icon
5
Biogen
BIIB
$29.9B
$4.86M 3.96%
16,144
-140
-0.9% -$44.7K
CM icon
6
Canadian Imperial Bank of Commerce
CM
$107B
$4.71M 3.83%
126,262
+470
+0.4% +$20K
RTX icon
7
RTX Corp
RTX
$287B
$4.51M 3.68%
67,315
-642
-0.9% -$50.4K
TEL icon
8
TE Connectivity
TEL
$58.8B
$4.15M 3.38%
54,868
-865
-2% -$66.6K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$3.9T
$4.02M 3.28%
77,640
-600
-0.8% -$32.1K
BN icon
10
Brookfield
BN
$102B
$3.95M 3.22%
288,681
-1,962
-0.7% -$29.3K
BMY icon
11
Bristol-Myers Squibb
BMY
$127B
$3.85M 3.14%
74,078
+7,551
+11% +$406K
DHR icon
12
Danaher
DHR
$135B
$3.78M 3.08%
41,325
-240
-0.6% -$21.8K
GILD icon
13
Gilead Sciences
GILD
$161B
$3.6M 2.93%
57,528
-5,499
-9% -$384K
CVS icon
14
CVS Health
CVS
$137B
$3.45M 2.81%
52,700
-197
-0.4% -$14.7K
BAX icon
15
Baxter International
BAX
$11.6B
$3.34M 2.72%
50,758
-332
-0.6% -$22.3K
GS icon
16
Goldman Sachs
GS
$313B
$3.13M 2.55%
+18,768
New +$3.79M
TRP icon
17
TC Energy
TRP
$73.5B
$3.1M 2.52%
86,785
-2,419
-3% -$95.4K
LYB icon
18
LyondellBasell Industries
LYB
$19.5B
$2.94M 2.39%
35,340
+110
+0.3% +$10.1K
VZ icon
19
Verizon
VZ
$194B
$2.57M 2.09%
45,697
-1,285
-3% -$72.9K
EMR icon
20
Emerson Electric
EMR
$82.9B
$2.49M 2.03%
41,645
-50
-0.1% -$3.37K
T icon
21
AT&T
T
$165B
$2.43M 1.98%
112,631
-627
-0.6% -$14.6K
J icon
22
Jacobs Solutions
J
$15.9B
$2.42M 1.98%
50,146
-568
-1% -$32.5K
CI icon
23
Cigna
CI
$76.6B
$2.27M 1.85%
11,975
+2,825
+31% +$589K
BCE icon
24
BCE
BCE
$19.9B
$2.16M 1.76%
54,755
-225
-0.4% -$9.21K
DE icon
25
Deere & Co
DE
$170B
$2.05M 1.67%
13,766

Similar funds

Lipe & Dalton's Q4 2018 Portfolio in Review

As of Q4 2018, Lipe & Dalton held 73 positions worth $123M, down 16% from $147M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lipe & Dalton's Q4 2018 filing shows 3 new, 15 increased, 31 reduced and 5 closed positions. Its largest new stake was Goldman Sachs: 18,768 shares worth $3.13M. The largest sale was Citigroup, an estimated $3.31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Lipe & Dalton's largest Q4 2018 buy was Goldman Sachs: 18,768 shares worth $3.13M.
  • Lipe & Dalton added most to Cigna in Q4 2018, an estimated $589K increase.
  • Lipe & Dalton's biggest Q4 2018 reduction was Citigroup, cutting an estimated $3.31M.
  • Lipe & Dalton fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $1.21M.
  • Lipe & Dalton's ten largest holdings make up 39% of its $123M portfolio in Q4 2018.
  • Lipe & Dalton opened 3 new positions and closed 5 in Q4 2018.
  • Lipe & Dalton's portfolio value fell 16% quarter-over-quarter to $123M.

Based on Lipe & Dalton's 13F filing for Q4 2018, filed 8 Feb 2019.